FDA Inspection 1134479 — Cancer Prevention Pharmaceuticals, Inc.
The FDA completed an inspection of Cancer Prevention Pharmaceuticals, Inc. on March 23, 2021 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tucson, AZ (United States)
Additional Details
Sponsor, Contract Research Organization